{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:25:10Z","timestamp":1787109910533,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":4947,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.anpedi.2012.08.015","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T21:01:16Z","timestamp":1349816476000},"page":"123.e1-123.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metilfenidato en el tratamiento del trastorno de d\u00e9ficit de atenci\u00f3n con hiperactividad en pediatr\u00eda: monitorizaci\u00f3n en matrices biol\u00f3gicas"],"prefix":"10.1016","volume":"78","author":[{"given":"E.","family":"Papaseit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Garc\u00eda-Algar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sim\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Farr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2012.08.015_bib0005","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/ajp.2007.164.6.942","article-title":"The worldwide prevalence of ADHD: a systematic review and metaregression analysis","volume":"164","author":"Polanczyk","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0010","first-page":"10","article-title":"Estimation of the prevalence of attention deficit hyperactivity disorder among the standard population on the island of Majorca","volume":"44","author":"Cardo","year":"2007","journal-title":"Rev Neurol"},{"issue":"40 Suppl. 1","key":"10.1016\/j.anpedi.2012.08.015_bib0015","first-page":"S11","article-title":"The prevalence of attention deficit hyperactivity disorder","volume":"15","author":"Cardo","year":"2005","journal-title":"Rev Neurol"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0020","series-title":"DSM-IV TR Manual diagn\u00f3stico y estad\u00edstico de los trastornos mentales-IV (texto revisado)","year":"2001"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0025","unstructured":"Attention deficit hyperactivity disorder. Diagnosis and management of ADHD in children, young people and adults. NICE clinical guideline 72. Issue date: September 2008. Developed by the National Collaborating Centre for Mental Health Attention deficit. Disponible en: http:\/\/guidance.nice.org.uk\/CG72\/NICEGuidance\/pdf\/English [consultado 14 Jun 2012]."},{"key":"10.1016\/j.anpedi.2012.08.015_bib0030","series-title":"Attention defi cit and hyperkinetic disorders in children and young people","year":"2009"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00004583-199704000-00016","article-title":"Effects of methylphenidate on attention and nonverbal learning in children with attention-deficit hyperactivity disorder","volume":"36","author":"O\u2019Toole","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0040","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/clpt.1992.185","article-title":"Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder","volume":"52","author":"Srinivas","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-5347(25)00340-4","article-title":"Pharmacology of the enantiomers of threo-methylphenidate","volume":"241","author":"Patrick","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0050","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1056-4993(18)30108-1","article-title":"The stimulants revisited","volume":"9","author":"Wilens","year":"2000","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0055","doi-asserted-by":"crossref","first-page":"10388","DOI":"10.1073\/pnas.93.19.10388","article-title":"Relationship between psychostimulant-induced \u201chigh\u201d and dopamine transporter occupancy","volume":"93","author":"Volkow","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/syn.10038","article-title":"Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications","volume":"43","author":"Volkow","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0065","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.neuroimage.2006.10.014","article-title":"Brain dopamine transporter levels in treatment and drug na\u00efve adults with ADHD","volume":"34","author":"Volkow","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0022-3565(25)30016-9","article-title":"Metabolism and disposition of methylphenidate-14C: studies in man and animals","volume":"191","author":"Faraj","year":"1974","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1023\/A:1007560500301","article-title":"Bioequivalence of methylphenidate immediate-release tablets using a replicated study design to characterize intrasubject variability","volume":"17","author":"Meyer","year":"2000","journal-title":"Pharm Res"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0080","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0009-9120(80)80007-5","article-title":"Gas chromatographic\/mass spectrometric analysis of methylphenidate (ritalin) in serum","volume":"13","author":"Chan","year":"1980","journal-title":"Clin Biochem"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/00003088-200342040-00007","article-title":"Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults","volume":"42","author":"Markowitz","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0090","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0090-9556(25)07963-2","article-title":"A study of methylphenidate in man with respect to its major metabolite","volume":"10","author":"Redalieu","year":"1982","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/00912700022009080","article-title":"Single and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation","volume":"40","author":"Modi","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1023\/A:1018956526016","article-title":"Enantioselective pharmacokinetics of dl-threo-methylphenidate in humans","volume":"10","author":"Srinivas","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0105","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jps.2600810805","article-title":"Stereoselective urinary pharmacokinetics of dl-threo-methylphenidate and its major metabolite in humans","volume":"81","author":"Srinivas","year":"1992","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0110","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2165\/00023210-200418140-00005","article-title":"New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential","volume":"18","author":"Connor","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0115","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1592\/phco.23.12.1281.32697","article-title":"Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations","volume":"23","author":"Markowitz","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0120","unstructured":"Agencia Esspa\u00f1ola del Medicamento y Productos Sanitarios. Disponible en: http:\/\/www.aemps.gob.es\/ [consultado 14 Jun 2012]."},{"key":"10.1016\/j.anpedi.2012.08.015_bib0125","unstructured":"Disponible en: http:\/\/www.rxlist.com\/script\/main\/hp.asp [consultado 14 Jun 2012]."},{"key":"10.1016\/j.anpedi.2012.08.015_bib0130","unstructured":"Disponible en: http:\/\/www.pharmanews.eu\/shire\/157-shire-withdraws-european-application-for-daytrana [consultado 14 Jun 2012]."},{"key":"10.1016\/j.anpedi.2012.08.015_bib0135","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1542\/peds.109.3.e39","article-title":"A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit\/hyperactivity disorder","volume":"109","author":"Greenhill","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00787-010-0140-6","article-title":"European guidelines on managing adverse effects of medication for ADHD","volume":"20","author":"Graham","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0009-9236(99)70038-X","article-title":"Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children","volume":"66","author":"Swanson","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mehy.2011.03.015","article-title":"Stimulants and growth in children with attention-deficit\/hyperactivity disorder","volume":"77","author":"Negrao","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0155","first-page":"994","article-title":"Effect of stimulants on height and weight: a review of the literature","volume":"47","author":"Faraone","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0160","unstructured":"Disponible en: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm279011.htm [consultado 14 Jun 2012]."},{"key":"10.1016\/j.anpedi.2012.08.015_bib0165","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1056\/NEJMoa1110212","article-title":"ADHD drugs and serious cardiovascular events in children and young adults","volume":"365","author":"Cooper","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/ebmental-2011-100514","article-title":"Use of ADHD drugs in children and young adults does not increase risk of serious cardiovascular adverse events compared with non-use","volume":"15","author":"Winterstein","year":"2012","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0175","unstructured":"Disponible en: http:\/\/www.incb.org\/pdf\/s\/conv\/convention_1971_es.pdf [consultado 14 Jun 2012]."},{"key":"10.1016\/j.anpedi.2012.08.015_bib0180","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00008877-199406000-00005","article-title":"Reinforcing and subjective effects of methylphenidate in humans","volume":"5","author":"Chait","year":"1994","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0185","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0091-3057(01)00464-6","article-title":"Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review","volume":"68","author":"Kollins","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0190","doi-asserted-by":"crossref","first-page":"PL7","DOI":"10.1016\/S0024-3205(99)00225-8","article-title":"Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain","volume":"65","author":"Volkow","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0195","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12402-010-0026-y","article-title":"A case of suicide attempt with long-acting methylphenidate (Concerta)","volume":"2","author":"Ozdemir","year":"2010","journal-title":"Atten Defic Hyperact Disord"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/08897070209511486","article-title":"Megadose intranasal methylphenidate (ritalin) abuse in adult attention deficit hyperactivity disorder","volume":"23","author":"Coetzee","year":"2002","journal-title":"Subst Abus"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0205","first-page":"773","article-title":"Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD","volume":"30","author":"Jaffe","year":"1991","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0210","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1520\/JFS14440J","article-title":"A fatality due to the intranasal abuse of methylphenidate (Ritalin)","volume":"44","author":"Massello","year":"1999","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0215","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00004583-199806000-00006","article-title":"Intranasal abuse of prescribed methylphenidate","volume":"37","author":"Garland","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0220","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0196-0644(85)80790-3","article-title":"Multiple organ failure resulting from intravenous abuse of methylphenidate hydrochloride","volume":"14","author":"Stecyk","year":"1985","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00004836-198404000-00010","article-title":"Hepatic dysfunction due to intravenous abuse of methylphenidate hydrochloride","volume":"6","author":"Mehta","year":"1984","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0230","doi-asserted-by":"crossref","first-page":"w13267","DOI":"10.4414\/smw.2011.13267","article-title":"Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets","volume":"141","author":"Bruggisser","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1747-597X-2-32","article-title":"The nonmedical use of prescription ADHD medications: results from a national Internet panel","volume":"2","author":"Novak","year":"2007","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0240","unstructured":"Monitoring The Future. National survey results on drug use, 1975-2010 Disponible en http:\/\/monitoringthefuture.org\/pubs\/monographs\/mtf-vol1_2010.pdf [consultado 14 Jun 2012]."},{"key":"10.1016\/j.anpedi.2012.08.015_bib0245","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00004714-199908000-00013","article-title":"Detection of the novel metabolite ethylphenidate after methylphenidate overdose with alcohol coingestion","volume":"19","author":"Markowitz","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0250","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/sj.clpt.6100082","article-title":"Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics","volume":"81","author":"Patrick","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0255","first-page":"238","article-title":"Influence of ethanol on the pharmacokinetics of methylphenidate's metabolites ritalinic acid and ethylphenidate","volume":"60","author":"Koehm","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0260","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jchromb.2011.02.033","article-title":"Enantiospecific determination of DL-methylphenidate and DL-ethylphenidate in plasma by liquid chromatography-tandem mass spectrometry: application to human ethanol interactions","volume":"879","author":"Zhu","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0031-3955(05)70460-0","article-title":"Noninvasive methods for drug measurement in pediatrics","volume":"44","author":"Bailey","year":"1997","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0270","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00003088-199630030-00003","article-title":"Drug monitoring in nonconventional biological fluids and matrices","volume":"30","author":"Pichini","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0275","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-4347(00)80704-5","article-title":"Development of enantioselective gas chromatographic quantitation assay for dl-threo-methylphenidate in biological fluids","volume":"378","author":"Lim","year":"1986","journal-title":"J Chromatogr"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0280","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.forsciint.2009.12.038","article-title":"Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject","volume":"20","author":"Marchei","year":"2010","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0285","first-page":"203","article-title":"A sensitive gas chromatographic method for the determination of methylphenidate (Ritalin) and its major metabolite alpha-phenyl-2-piperidine acetic acid (ritalinic acid) in human plasma using nitrogen-phosphorous detector","volume":"2","author":"Hungund","year":"1978","journal-title":"Commun Psychopharmacol"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0290","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1542\/peds.69.6.688","article-title":"Psychopharmacology of attention deficit disorder: pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate","volume":"69","author":"Shaywitz","year":"1982","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0295","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00449120","article-title":"Methylphenidate dosis oral plasma concentrations and behavioral response in children","volume":"76","author":"Winsberg","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0300","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0022-3565(25)21542-7","article-title":"Pharmacokinetics of methylphenidate in man, rat and monkey","volume":"226","author":"Wargin","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0305","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1542\/peds.72.1.56","article-title":"Methylphenidate hydrochloride given with or before breakfast: II. Effects on plasma concentration of methylphenidate and ritalinic acid","volume":"72","author":"Chan","year":"1983","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0310","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00007691-198412000-00001","article-title":"Clinical correlates of methylphenidate blood levels","volume":"6","author":"Gualtieri","year":"1984","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0315","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/jps.2600781113","article-title":"Enantioselective aspects of the disposition of dl-threo-methylphenidate after the administration of a sustained-release formulation to children with attention deficit-hyperactivity disorder","volume":"78","author":"Hubbard","year":"1989","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0320","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1089\/cap.2006.16.416","article-title":"Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens","volume":"16","author":"Teicher","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0325","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/cap.2007.0043","article-title":"Pharmacokinetics of methylphenidate in preschoolers with attention-deficit\/hyperactivity disorder","volume":"17","author":"Wigal","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0330","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1177\/0091270007299759","article-title":"Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit\/hyperactivity disorder","volume":"47","author":"Quinn","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0335","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jps.2600790602","article-title":"Kinetic analysis of enantiomers of threo-methylphenidate and its metabolite in two healthy subjects after oral administration as determined by a gas chromatographic-mass spectrometric method","volume":"79","author":"Aoyama","year":"1990","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0340","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/(SICI)1097-0231(19991030)13:20<2054::AID-RCM749>3.0.CO;2-5","article-title":"Liquid chromatography\/atmospheric pressure chemical ionization tandem mass spectrometry enantiomeric separation of dl-threo-methylphenidate. (Ritalin) using a macrocyclic antibiotic as the chiral selector","volume":"13","author":"Ramos","year":"1999","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0345","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0378-4347(94)00234-7","article-title":"Simultaneous detection of methylphenidate and its main metabolite, ritalinic acid, in doping control","volume":"658","author":"Solans","year":"1994","journal-title":"J Chromatogr B Biomed Appl"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0350","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jchromb.2011.11.007","article-title":"Determination of methylphenidate and its metabolite ritalinic acid in urine by liquid chromatography\/tandem mass spectrometry","volume":"15","author":"Paterson","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0355","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jpba.2008.11.020","article-title":"Liquid chromatography-electrospray ionization mass spectrometry determination of methylphenidate and ritalinic acid in conventional and non-conventional biological matrices","volume":"49","author":"Marchei","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0360","first-page":"115","article-title":"Methylphenidate salivary levels in children","volume":"23","author":"Greenhill","year":"1987","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0365","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/JCP.0b013e3181f0c2f6","article-title":"Single- and multiple-dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic-release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder","volume":"30","author":"Pierce","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0370","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.forsciint.2011.10.024","article-title":"Society of Hair Testing guidelines for drug testing in hair","volume":"10","author":"Cooper","year":"2012","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0375","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/jat\/31.9.588","article-title":"Detection of methylphenidate in the hair of children treated with Ritalin","volume":"31","author":"Sticht","year":"2007","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.anpedi.2012.08.015_bib0380","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.forsciint.2007.06.024","article-title":"Development and validation of a liquid chromatography-mass spectrometry assay for hair analysis of methylphenidate","volume":"176","author":"Marchei","year":"2008","journal-title":"Forensic Sci Int"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403312003797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403312003797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:35:35Z","timestamp":1787106935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403312003797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1695403312003797"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2012.08.015","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metilfenidato en el tratamiento del trastorno de d\u00e9ficit de atenci\u00f3n con hiperactividad en pediatr\u00eda: monitorizaci\u00f3n en matrices biol\u00f3gicas","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2012.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}